1,000
Participants
Start Date
April 5, 2019
Primary Completion Date
November 1, 2024
Study Completion Date
November 1, 2024
Enhanced Screening Protocol for Cardiac Sarcoidosis.
To utilize enhanced screening tests for cardiac sarcoidosis in an undiagnosed and potentially under-diagnosed patient population to determine the rate of missed cardiac sarcoidosis diagnosis. Following testing by the standard screening tests, this intervention includes a subsequent echocardiogram and a wearable ECG, also known as a Holter Monitor or ambulatory ECG.
Routine Screening for Suspected Cardiac Sarcoidosis
To utilize standard of care screening tests for cardiac sarcoidosis. This includes symptom check and a standard ECG.
Albany Medical Center, Albany
Penn Medicine, Philadelphia
Medical University of South Carolina, Charleston
Cleveland Clinic, Cleveland
University of Cincinnati Medical Center, Cincinnati
University of Iowa Hospital, Iowa City
Northwestern University Medicine, Chicago
University of Illinois Medical Center At Chicago, Chicago
National Jewish Health, Denver
University of Washington Medical Center, Seattle
St. Antonius, Amsterdam
Royal Papworth Hospital, Cambridge
Foundation for Sarcoidosis Research
OTHER